UNIVPHOTO.NS Universus Photo Imagings NSE up 20% intraday 14 Feb 2026: watch volume-led momentum

UNIVPHOTO.NS stock rose sharply intraday on 14 Feb 2026, trading at INR 256.10, up 20.00% from the previous close. The move came on a volume spike of 27,574 shares against an average of 4,985, giving a relative volume of 5.52. Traders cited the gap open at INR 217.00 and strong buying into the day high INR 256.10. We track how fundamentals, technicals, and Meyka AI projections shape the short-term trade idea for Universus Photo Imagings Limited on the NSE.

UNIVPHOTO.NS stock intraday move and volume drivers

Today Universus Photo Imagings Limited (UNIVPHOTO.NS) hit a day high of INR 256.10. The stock gained INR 42.68, a 20.00% rise on 27,574 shares, well above the 4,985 average.

The surge shows momentum traders and short-term buyers. Higher-than-normal volume and a gap open at INR 217.00 indicate intraday accumulation rather than a lone spike.

UNIVPHOTO.NS stock fundamentals and valuation

UNIVPHOTO.NS shows mixed fundamentals: book value per share is INR 768.33, cash per share INR 242.65, and revenue per share INR 17.87. The company reports EPS of -139.79 and a trailing PE of -1.83, reflecting recent losses.

Valuation ratios are uneven: price-to-book is 0.33, while price-to-sales is 14.33. The low PB but negative earnings suggest a balance-sheet rich company with profitability challenges.

Technical view and trading setup for UNIVPHOTO.NS stock

Technically, UNIVPHOTO.NS is near today’s upper band at INR 256.10, with Bollinger upper band at INR 243.63 and middle at INR 227.45. RSI reads 30.29, and CCI shows oversold readings earlier, implying high swing volatility.

Short-term support sits near the day low INR 210.00 and the 50-day average INR 215.29. Traders seeking momentum may watch a confirmed close above INR 256.10 for a move toward the year high INR 333.40.

Meyka AI rates and analyst summary for UNIVPHOTO.NS stock

Meyka AI rates UNIVPHOTO.NS with a score of 70.33 out of 100 — Grade B+, Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, forecasts, and analyst consensus.

Note: the company rating database shows a third-party grade of C dated 13 Feb 2026 with a Sell recommendation on some metrics. Our proprietary grade balances that view with balance-sheet strength and forecast upside. These grades are not guarantees and are informational only.

Catalysts, risks and sector context for UNIVPHOTO.NS stock

Catalysts include inventory turnaround, renewed demand in imaging and medical films, and the recent earnings release on 10 Feb 2026. The Healthcare sector average PB is 4.81, while UNIVPHOTO.NS trades at 0.33, highlighting valuation divergence.

Risks include negative EPS, tight margins, and high price-to-sales of 14.33. Sector peers show stronger profitability, so any market rotation away from small-cap healthcare names could pressure UNIVPHOTO.NS.

Price forecasts and realistic targets for UNIVPHOTO.NS stock

Meyka AI’s forecast model projects a 1-year price of INR 236.86. Against the current INR 256.10, that implies an expected downside of -7.51%. Shorter-horizon forecasts include a monthly projection of INR 190.35.

For trading we lay out scenario targets: short-term resistance INR 290.00, medium-term upside to the year high INR 333.40, and a conservative model target INR 236.86. Forecasts are model-based projections and not guarantees.

Final Thoughts

UNIVPHOTO.NS stock is a top intraday gainer on 14 Feb 2026, with price at INR 256.10, a 20.00% rise and a clear volume surge. The move reflects short-term momentum rather than an immediate fundamental turnaround. Balance-sheet strengths include INR 242.65 cash per share and book value INR 768.33 per share. Offsetting this are negative EPS (-139.79) and a negative PE (-1.83). Meyka AI’s forecast model projects INR 236.86 over 12 months, implying -7.51% from today’s price; this is our conservative baseline scenario. Traders should treat today’s jump as a momentum trade, watch for a confirmed close above INR 256.10, and set tight stops near INR 210.00. For longer-term investors, valuation gaps versus healthcare peers mean the case rests on profit recovery and consistent revenue growth. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts and grades are model outputs and not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.